COVID-19 vaccine hesitancy among people living with HIV in a low-resource setting: A multi-center study of prevalence, correlates and reasons
暂无分享,去创建一个
Gambo Ibrahim | Farouq Muhammad Dayyab | Bashir Dabo | A. Yakubu | Sahabi Kabir Sulaiman | Muhammad Sale Musa | Fatimah Isma'il Tsiga-Ahmed | Abdulwahab Kabir Sulaiman | Saidu Idris Ahmad | Salisu Abubakar Haruna | Abdullahi Abdurrahman Zubair | Aminu Hussein | Sadiya Usman | Jummai Usman Wada | Ayoola Yekeen Ayodele | Muhammed Wulgo Ali | Bello Tijjani Makama | Abdulaziz Tijjani Bako | Islam Alhaji Fatima Abubakar Abdulkadir Najib Bashir Muk Umar Bello Muhammad Isa Shettima Ali Garba | Islam Umar Bello | Alhaji Muhammad Isa | Fatima Shettima Ali | Abubakar Garba Ismail | Abdulkadir Dalhatu Abdulkadir | Najib Jamal Abdulnasir | Bashir Zakar Gambo | Mukhtar Usman Mustapha | Mustapha Mohammed | Hadiza Adamu Dogo | Fatima Ishaq Abubakar | Yakubu kurugu | Garba Auwal Yusufari | Salamatu Saleh | Saeed Sulaiman
[1] C. Demirdover. COVID-19-vaccines , 2021, Reactions Weekly.
[2] E. Manirambona,et al. Assessment of COVID-19 vaccine hesitancy among people living with HIV/AIDS: a single-centered study , 2023, PAMJ - One Health.
[3] R. King,et al. COVID-19 vaccine acceptability, and uptake among people living with HIV in Uganda , 2022, PloS one.
[4] J. Lazarus,et al. COVID-19 vaccine acceptance and associated factors among people living with HIV in the Middle East and North Africa region , 2022, Southern African journal of HIV medicine.
[5] A. Nguyen,et al. Determinants of COVID-19 vaccine acceptability among older adults living with HIV , 2022, Medicine.
[6] Zixin Wang,et al. COVID-19 Vaccination Uptake Among a Nationwide Sample of People Living With HIV During the Early Phase of Vaccine Rollout in China , 2022, Frontiers in Medicine.
[7] B. Lu,et al. Acceptance of COVID-19 vaccination and influencing factors among people living with HIV in Guangxi, China: a cross-sectional survey , 2022, BMC Infectious Diseases.
[8] K. Liang,et al. COVID-19 Vaccination Willingness Among People Living With HIV in Wuhan, China , 2022, Frontiers in Public Health.
[9] N. Ford,et al. Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19 , 2022, The Lancet HIV.
[10] A. Rodríguez-Morales,et al. Willingness to receive COVID-19 vaccination in people living with HIV/AIDS from Latin America , 2022, International journal of STD & AIDS.
[11] I. Bassett,et al. Willingness to accept COVID-19 vaccination among people living with HIV in a high HIV prevalence community , 2022, BMC Public Health.
[12] Jeffrey A. Wickersham,et al. COVID-19 Vaccine Hesitancy and Associated Factors among People with HIV in the United States: Findings from a National Survey , 2022, Vaccines.
[13] J. Alqahtani,et al. Global and Regional Prevalence and Outcomes of COVID-19 in People Living with HIV: A Systematic Review and Meta-Analysis , 2022, Tropical medicine and infectious disease.
[14] A. Subramanian,et al. COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus , 2022, Infectious Disease Clinics of North America.
[15] J. D. de Wit,et al. COVID-19 Vaccination Uptake and Hesitancy in a National Sample of Australian Gay and Bisexual Men , 2022, AIDS and Behavior.
[16] J. Yombi,et al. Outcomes of patients with HIV and COVID-19 co-infection: a systematic review and meta-analysis , 2022, AIDS Research and Therapy.
[17] Karan Varshney,et al. Risk Factors for COVID-19 Mortality Among People Living with HIV: A Scoping Review , 2022, AIDS and Behavior.
[18] P. Nyasulu,et al. Systematic review and meta-analysis of COVID-19 vaccines safety, tolerability, and efficacy among HIV-infected patients , 2022 .
[19] Jianzhou Yang,et al. Reasons for COVID-19 Vaccine Hesitancy Among Chinese People Living With HIV/AIDS: Structural Equation Modeling Analysis , 2021, JMIR public health and surveillance.
[20] L. Galea,et al. Intention to Receive a COVID-19 Vaccine by HIV Status Among a Population-Based Sample of Women and Gender Diverse Individuals in British Columbia, Canada , 2021, AIDS and Behavior.
[21] U. V. Ukah,et al. COVID-19 vaccine hesitancy in Africa: a scoping review , 2021, Global Health Research and Policy.
[22] H. Salihu,et al. Predictors of COVID-19 vaccine acceptability among patients living with HIV in northern Nigeria: A mixed methods study. , 2021, Current HIV research.
[23] Kristen D. Krause,et al. SARS-CoV-2 Vaccination Hesitancy and Behaviors in a National Sample of People Living with HIV. , 2021, AIDS patient care and STDs.
[24] H. Zou,et al. Uptake and adverse reactions of COVID-19 vaccination among people living with HIV in China: a case–control study , 2021, Human vaccines & immunotherapeutics.
[25] Yawen Jiang,et al. COVID-19 vaccine uptake and hesitancy among HIV-infected men who have sex with men in mainland China: a cross-sectional survey , 2021, Human vaccines & immunotherapeutics.
[26] Y. Mesfin,et al. Factors Associated with Intention to Receive COVID-19 Vaccine Among HIV Positive Patients Attending ART Clinic in Southwest Ethiopia , 2021, Patient preference and adherence.
[27] Xuesen Zhao,et al. COVID-19 Vaccination in People Living with HIV (PLWH) in China: A Cross Sectional Study of Vaccine Hesitancy, Safety, and Immunogenicity , 2021, Vaccines.
[28] M. Muszkat,et al. Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis , 2021, Scientific Reports.
[29] Charles Taylor,et al. The syndemic burden of HIV/AIDS in Africa amidst the COVID‐19 pandemic , 2021, Immunity, inflammation and disease.
[30] W. Steward,et al. COVID-19 Vaccine Hesitancy Among PLWH in South India: Implications for Vaccination Campaigns , 2021, Journal of acquired immune deficiency syndromes.
[31] Wenjing Pian,et al. The causes, impacts and countermeasures of COVID-19 “Infodemic”: A systematic review using narrative synthesis , 2021, Information Processing & Management.
[32] H. Zou,et al. Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials , 2021, Infectious Diseases of Poverty.
[33] Hui Jiang,et al. Willingness to Receive COVID-19 Vaccination Among People Living With HIV and AIDS in China: Nationwide Cross-sectional Online Survey , 2021, JMIR public health and surveillance.
[34] H. Larson,et al. Overcoming vaccine hesitancy in low-income and middle-income regions , 2021, Nature Reviews Disease Primers.
[35] Y. A. M. Elhadi,et al. Systematic Review and Meta-analysis on COVID-19 Vaccine Hesitancy , 2021, medRxiv.
[36] C. Robertson,et al. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study , 2021, BMJ.
[37] R. Balise,et al. Severe Acute Respiratory Syndrome Coronavirus 2: Vaccine Hesitancy Among Underrepresented Racial and Ethnic Groups With HIV in Miami, Florida , 2021, Open forum infectious diseases.
[38] A. Vallée,et al. COVID-19 Vaccine Hesitancy among French People Living with HIV , 2021, Vaccines.
[39] V. Chinchilli,et al. Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis , 2021, Scientific Reports.
[40] M. Y. Essar,et al. Vaccine hesitancy in Africa: causes and strategies to the rescue , 2021, Therapeutic advances in vaccines and immunotherapy.
[41] M. Daly,et al. International estimates of intended uptake and refusal of COVID-19 vaccines: A rapid systematic review and meta-analysis of large nationally representative samples , 2020, Vaccine.
[42] T. Stoppani. Mapping , 2004, Encyclopedia of the UN Sustainable Development Goals.
[43] Jialin C. Zheng,et al. Safety, Tolerability, and Immunogenicity of COVID-19 Vaccines: A Systematic Review and Meta-Analysis , 2020, medRxiv.
[44] R. Sartorius,et al. Viral Emerging Diseases: Challenges in Developing Vaccination Strategies , 2020, Frontiers in Immunology.
[45] K. Kim,et al. What Is COVID-19? , 2020, Frontiers for Young Minds.
[46] A. Jan,et al. BMI Classification Percentile And Cut Off Points , 2019 .
[47] N. MacDonald,et al. Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015–2017 , 2018, Vaccine.
[48] M. Bornstein,et al. II. MORE THAN JUST CONVENIENT: THE SCIENTIFIC MERITS OF HOMOGENEOUS CONVENIENCE SAMPLES. , 2017, Monographs of the Society for Research in Child Development.
[49] Ilker Etikan,et al. Comparison of Convenience Sampling and Purposive Sampling , 2016 .
[50] N. MacDonald. Vaccine hesitancy: Definition, scope and determinants. , 2015, Vaccine.
[51] È. Dubé,et al. Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications , 2015, Expert review of vaccines.
[52] È. Dubé,et al. Mapping vaccine hesitancy—Country-specific characteristics of a global phenomenon , 2014, Vaccine.
[53] N. Sevdalis,et al. Attitudes to vaccination: a critical review. , 2014, Social science & medicine.
[54] Heidi J Larson,et al. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. , 2014, Vaccine.
[55] World Medical Association (WMA),et al. Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects , 2009, Journal of the Indian Medical Association.
[56] A. Jegede. What Led to the Nigerian Boycott of the Polio Vaccination Campaign? , 2007, PLoS medicine.
[57] Stanley Lemeshow,et al. Assessing the Fit of the Model , 2005 .
[58] J. Wise. Pfizer accused of testing new drug without ethical approval , 2001, BMJ : British Medical Journal.
[59] Stanley Lemeshow,et al. Sample Size Determination in Health Studies: A Practical Manual , 1991 .